Our members, volunteers, and customers have made CLSI a respected leader in developing standards that improve the quality of patient care.
CLSI’s newborn screening standards provide the critical guidance needed to detect potentially life-threatening and debilitating conditions for better outcomes and healthy, happy infants.
Through our educational resources and Global Health Partnerships program, CLSI helps clinical laboratories implement quality practices for better health worldwide.
This program will provide an introduction to molecular diagnostics for those laboratories considering implementing or expanding testing. It will emphasize the special opportunities and challenges associated with molecular diagnostic testing and discuss how the CLSI molecular methods documents can help laboratories successfully implement testing.
Understanding the Cost of Quality in the Laboratory (QMS20-R) is a valuable report that provides guidance to a lab in understanding and managing the different types of quality costs that affect processes, services, and financial well-being.
|CAP Crosswalk||CLMA Crosswalk||FDA Crosswalk||ISO Crosswalk||Joint Commission Crosswalk|
09.04.14CLSI Released an Updated Method Evaluation Standard on the Evaluation of Commutability of Processed Samples
08.12.14CLSI Releases New Microbiology Standard for Detection of Anaerobes in Clinical Specimens